This site is intended only for healthcare professionals resident in the United Kingdom
ReFacto AF® – Live life more freely
ReFacto AF (moroctocog alfa – recombinant coagulation factor VIII) is indicated for the treatment and prophylaxis of bleeding in patients with Haemophilia A (congenital factor VIII deficiency).
"By clicking "confirm" to create an account, you confirm that the information you have provided above is correct, and you agree to (i) Pfizer’s processing of your personal data, including its transfer internationally and to third parties, in accordance with the Pfizer Privacy and Cookie Policy; and (ii) Pfizer’s Website Terms of Use."
